About two million people in Germany suffer from osteoarthritis of the joints. Because of the high incidence and the often unsatisfactory outcomes, the need for safe and effective orthopaedic treatment methods is very high. Under the pressure of the increasing annual number of joint operations for osteoarthritis (so-called total endoprosthesis, for short: TEP), as well as other surgical procedures such as arthroscopy, and the resulting cost burden on the healthcare system in Germany, there is a huge need for the expansion of existing as well as new conservative treatment methods.

In other words: For medical procedures for preserving the knee joint without requiring surgery. Enter ORTHOGEN Lab Services GmbH. The EOT®II syringe is used in the context of non-surgical treatment for osteoarthritis and joint problems. The patented process enables the attending physician to produce autologous conditioned serum (for short: ACS) using the EOT®II syringe in the laboratory.


    • Use of EOT®II in treatment of meniscal lesions and sports injuries
      Impressive results presented at 2018 meeting of international Orthogen partners

      International partners ensure the availability of Orthogen’s EOT®II system in European and Asian countries and in Australia. The annual Orthogen partners’ meeting 2018 gathered participants from twelve countries and three continents in Düsseldorf, Germany, to discuss the latest developments.

      • 7 Years of Successful Patient Treatment – Osteo Klouby Klinik Prague

        Doctor Dalibor Zeman from Prague Osteo Kloubi Clinic has been using EOT®II since February 2011. More than 500 patients have been treated with Orthogen's EOT®II method.

        • Avoiding Surgery in 83% of Patients with Meniscal Lesions by using EOT®II

          The results of a retrospective study assessing the use of the EOT®II system in the treatment of painful meniscal lesions were published recently (Strümper R (2017). Sports Medicine International Open 2017; 1: E200–E205).

          • Specialists meet in Madrid, Spain, to discuss use of the EOT®II system

            On November 17, 2017, over 70 physicians from private practices and hospitals all over Spain met in Madrid to discuss current applications of the EOT®II system.

          • Orthogen Lab Services Distributionsmeeting Düsseldorf
            • International Distributor’s Meeting
              in Dusseldorf

              The annual International Orthogen Distributor’s Meeting 2017 will take place in Düsseldorf, Germany, from January 19 to 21.

              • ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc
                in Moscow

                ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc in Moscow work together to better treat Osteoarthritis. ORTHOGEN’s innovative EOT®II blood preparation kit is used for the benefit of Gazprom employees in Russia.